ResMed Earnings Per Share

RMD -- USA Stock  

USD 108.81  0.39  0.36%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Earnings Per Share Analysis

Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share 
Average Shares 
1.99 times

About Earnings Per Share

Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.Compare to competition
According to company disclosure ResMed has Earnings Per Share of 1.99 times. This is 165.33% higher than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Earnings Per Share for all stocks is 13.48% higher than the company.

Peer Comparison

ResMed Earnings Per Share Comparison
ResMed is currently under evaluation in earnings per share category among related companies.

Current ResMed financial ratios

Return On Equity15.68 %
Return On Asset9.58 %
Profit Margin13.52 %
Operating Margin28.58 %
Current Valuation15.35 B
Shares Outstanding142.74 M
Shares Owned by Insiders1.14 %
Shares Owned by Institutions64.13 %
Number of Shares Shorted3.76 M
Price to Earning55.05 times
Price to Book7.74 times
Price to Sales6.87 times
Revenue2.27 B
Gross Profit1.2 B
EBITDA649.65 M
Net Income307.39 M
Cash and Equivalents704.28 M
Cash per Share4.93 times
Total Debt810 M
Debt to Equity39.10 %
Current Ratio3.48 times
Book Value Per Share14.13 times
Cash Flow from Operations410.34 M
Short Ratio6.14 times
Earnings Per Share1.99 times
Price to Earnings To Growth2.64 times
Number of Employees6 K
Market Capitalization15.61 B
Total Asset3.26 B
Retained Earnings2.16 B
Working Capital781.73 M
Current Asset1.42 B
Current Liabilities637.99 M
Z Score11.4
Five Year Return1.82 %
Last Dividend Paid1.4